A plutocratic proposal
July 1, 2016
If mega-rich people could buy places on clinical trials, would this help drive forward the development of new treatments that could benefit everyone? Alexander Masters thinks it might just work.
Read more iCancer (ADVince) clinical trial begins
April 5, 2016
Thanks to YOU - the crowd - the iCancer clinical trial begins in Sweden
Read moreiCancer hits its goal raising £2million
June 15, 2013
We've done it
Read moreThe Coopers half marathon
March 1, 2013
Running for iCancer
Read moreThankyou and what next?
February 14, 2013
A huge thank you to everybody who has donated
Read moreiCancer in the media
October 10, 2012
A round-up of phenomenal press coverage
Read moreIf this anti-cancer virus is so brilliant why is there no funding for it?
Alexander Masters talks about why there is no funding for this anti-cancer virus and why big business will not invest.
Read moreIndependent expert Prof Alan Melcher talks about the science behind #iCancer
Independent analysis of iCancer
Read moreThe published scientific papers
Virus creator Prof Justyna Leja on the creation of the anti-cancer virus
Read moreThe cancer killer they won’t pay for – Telegraph
October 2, 2012
An author is launching a 'crowd-funding’ campaign to pay for vital research
Read more‘Would I take an untested cancer treatment myself? Hell, yes!’
September 12, 2012
Two weeks ago, Dominic Nutt read in the Telegraph about a possible cure for his rare cancer. But without funding – a paltry £2 million – it can’t go to trial. So, he asks, what price a life?.
Read moreAuthor appeals to Apple to fund cancer hope that could have saved Steve Jobs
September 1, 2012
A British author whose friend is slowly dying of the same cancer that killed Steve Jobs, has appealed to Apple to help fund development of a potential treatment that could have saved the billionaire.
Read moreA virus that kills cancer: the cure that’s waiting in the cold – Telegraph
August 31, 2012
Sitting in a refrigerator in a Swedish laboratory is what promises to be a cheap and effective cancer treatment. So why are the trials to bring it to market not going ahead?
Read more